ロード中...

1963. PrEP Significantly Reduces the Rate of New HIV Diagnoses in US Metropolitan Statistical Areas Independent of Treatment as Prevention (2012–2017)

BACKGROUND: Tenofovir/Emtricitabine (TVD) was approved for a Pre-exposure Prophylaxis (PrEP) indication in the United States in July 2012. Biomedical HIV prevention tools can impact the rate of new HIV diagnoses but their relative contributions have not been described. METHODS: The analysis utilized...

詳細記述

保存先:
書誌詳細
出版年:Open Forum Infect Dis
主要な著者: Mera-Giler, Robertino M, Das, Moupali, Hawkins, Trevor, Magnuson, David, Asubonteng, Julius, McCallister, Scott
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2019
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6808906/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz359.140
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!